High Therapeutic Effects GS-441524 5.5mL FIP GS 441524 For Cats FIPV
Basic Properties
Model Number:
GS-441524
Trading Properties
Minimum Order Quantity:
10 vials
Price:
Negotiable
Payment Terms:
L/C,D/A,D/P,T/T,Western Union
Supply Ability:
100000 vials per month
Specifications
| Function: | Cat FIPV | CAS: | 1191237-69-0 |
| Purity: | 20mg/mL | Shelf Life: | 2 Years |
| Test Method: | HPLC UV | Storage: | Cool Dry Place |
| Sample: | Available | Shipping Method: | Air(UPS, FedEx, TNT, EMS) Or Sea |
| MF: | C12H13N5O4 | Einecs No.: | 200-001-8 |
| Highlight: | High Therapeutic Effects GS-441524, GS-441524 5.5mL, 5.5mL Fip Gs 441524 |
Product Description
Gallery
High Therapeutic Effects GS-441524 5.5mL FIP GS 441524 For Cats FIPV


High Therapeutic Effects Cats FIPV 5.5mL GS-441524 Injection
Product Description
This medicine is an adenosine nucleotide analog antiviral, similar to remdesivi.This molecule was patented in 2009. In vitro studies of GS have determined it has a higher EC50 than remdesivi against a number of viruses, meaning GS is less potent.This medicine continues to be studied in the treatment of Feline Infectious Peritonitis Virus, that only infects cats.
| Appearance | Transparent liquid, powder or tablets |
| GS Standard | 99.5%min |
| Size | 5.5 ml/ Vial |
| Content | 15mg/ml or 20mg/ml |
| Application | For CAT FIP R&D Use ONLY |
| Wet FIP | 6-7 mg/kg |
| Dry FIP | 7-8 mg/kg |
| Ocular or Neuro FIP | 8 mg/kg |
| Increased ocular/neuro | 9 mg/kg |
| Max ocular/neuro | 10 mg/kg |
GS-441524 nucleoside is phosphorylated with the aid of using nucleoside kinases (likely adenosine kinase (ADK), that is the enzyme that phosphorylates the structurally comparable ribavirin), after which phosphorylated once more with the aid of using nucleoside-diphosphate kinase (NDK) to the energetic nucleotide triphosphate form. The triphosphate of GS-441524, GS-443902, is likewise the bioactive anti-viral agent generated with the aid of using remdesivir, however is generated with the aid of using a extraordinary biochemical mechanism from the later.
Intracellular triple-phosphorylation of GS-441524 yields its energetic 1'-cyano-substituted adenosine triphosphate analogue, which immediately disrupts viral RNA replication with the aid of using competing with endogenous NTPs for incorporation into nascent viral RNA transcripts and triggering not on time chain termination of RNA-structured RNA polymerase.
Since FIP is commonly deadly and there aren't anyt any permitted remedies available, GS-441524 has reportedly been offered at the black marketplace and utilized by puppy proprietors to deal with affected cats, despite the fact that Gilead Sciences has refused to license the Medicine for veterinary use. Its efficacy for this cause has been conclusively proven in more than one trials, together with discipline trials,or even in greater complex sorts of FIP together with people with multisystemic or neurological involvement.